GRANT INCOME	6 Months Ended
Jun. 30, 2026
Government Assistance [Abstract]
GRANT INCOME	NOTE 16 – GRANT INCOME Grant income of $0.8 million and $0.9 million for the three and six months ended June 30, 2026, respectively, attributable to research and development is netted against eligible expenses in Research and development (income) expense, net in the Condensed Consolidated Statements of Operations. Grant income attributable to research and development activities recognized during the comparable 2025 periods was nominal. Grant income totaling $20.7 million and $14.1 million attributable to project development is netted against Construction-in-process on the Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025, respectively. In 2024, the Company was awarded a reimbursement-type grant from the DOE in the amount of $22.1 million. The effective date of the grant was July 1, 2024, and the contract was extended through July 31, 2027. Funding under the grant is recognized as qualifying expenditures are incurred in accordance with the terms of the grant agreement. In 2025 and during the six months ended June 30, 2026, the Company has been awarded several smaller grants, totaling $0.7 million, which are accounted for consistent with the Company’s grant income policy.

GRANT INCOME

6 Months Ended

Jun. 30, 2026

NOTE 16 – GRANT INCOME

Grant income of $0.8 million and $0.9 million for the three and six months ended June 30, 2026, respectively, attributable to research and development is netted against eligible expenses in Research and development (income) expense, net in the Condensed Consolidated Statements of Operations. Grant income attributable to research and development activities recognized during the comparable 2025 periods was nominal. Grant income totaling $20.7 million and $14.1 million attributable to project development is netted against Construction-in-process on the Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025, respectively.

In 2024, the Company was awarded a reimbursement-type grant from the DOE in the amount of $22.1 million. The effective date of the grant was July 1, 2024, and the contract was extended through July 31, 2027. Funding under the grant is recognized as qualifying expenditures are incurred in accordance with the terms of the grant agreement. In 2025 and during the six months ended June 30, 2026, the Company has been awarded several smaller grants, totaling $0.7 million, which are accounted for consistent with the Company’s grant income policy.